RemeGen Co., Ltd., a commercial-ready biotechnology company, announced that two of its innovative drugs, a dual-targeted TACI-Fc fusion protein, Telitacicept (RC18) for treating systemic...
Roche and TIB Molbiol, a newly acquired subsidiary within the Roche Diagnostics division, have added three additional Research Use Only (RUO) test kits for...
Israeli startup, TriEye, the pioneer and developer of world's first CMOS-based SWIR sensing solutions, announces the addition of Hans Rijns, a senior semiconductor executive...
Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced that full results from...
The United States Pharmacopeia (USP) has drafted a commentary, It's time to hold cannabinoid products to the highest standard: USP Cannabis Panel statement on...
